Language selection

Search

Equine information document (EID)

On this page

1. Introduction

It is mandatory in Canada, for all licence holders (operators) engaged in equine slaughter for edible purposes, for each establishment where the activity is conducted with inspection services provided by the Canadian Food Inspection Agency (CFIA), to have, from the person who owned or had the possession, care or control of the equine before its arrival at the establishment, a record that contains identity and a complete medical history for all equine (domestic and imported) presented for slaughter.

These Food Animal Information Document (FAID) records are referred to as equine information documents (EID) and provide the operator with the necessary level of confidence that identified potential hazards associated with live equine animals have been recorded, and to the extent possible, prevented or controlled at the farm level and during transportation. The EID allows CFIA staff to judge if the required information by section 165 of the Safe Food for Canadians Regulations (SFCR) has been provided and that the operator is taking the necessary measures to evaluate incoming equine according to the written specification contained in their Preventive Control Plan (PCP).

A completed individual EID contains a standardized description of the animal, as well as a comprehensive record of the equine's medical history for at least the preceding 180 days. The information template provided in section 2 should be used by equine owners as an aid to provide all the required information for individual equine animals to the operator or adapted for use by the equine industry as long as it can offer the same level of confidence.

The completed and signed EID must accompany the equine, at the time of ownership transfer, to the buyer of the animal intended to slaughter.

An owner of a group(s)/lot(s) of equine animals, assembled with the intention of utilizing them as food animals, may be eligible to present the animals to slaughter via a collective (lot) declaration. For details refer to section 5.

2. EID elements

The information provided below represents the core elements of the EID for individual equine (horses, donkeys, zebras and their crosses) presented for slaughter in Canada and can be adapted with all the elements described, for use by the equine industry as long as it can offer the same level of confidence.

The EID must contain both written and visual identification, as well as medical history and declaration (Part 3), bearing the original signature, by the owner of the equine and any person who had the possession, care or control of it immediately before its arrival at the slaughter establishment. A provision included in the EID (see Part 3) allows for the transfer of a complete medical history when 1 or more transient agents are involved.

Alternate options to filling out the written description and picture identification below are given at the end of Part 1.

Part 1: Written and visual identification

a) Written information

Primary location of the animal

space
space
(Land location or legal address or premise identification number)

Primary use(s) of the animal

Circle 1 or more of the following:

Recreation/companion animal/pleasure riding, breeding, ranch/farm work, public work, private industry work, performance/sport/show, racing, rodeo, urine production, food animals production. If other please specify:

If other please specify: space

Sex: mare/filly, gelding, stallion/colt (circle 1)

Month and year of birth (if known) space

Country of birth (if known) space

Height in hands (1 hand = 4 inches) space

Refer to the EID, section 3 for terms to be used for the following equine colour and marking identification section.

Body colour : space

Markings:

The following supplemental identification items may be completed if applicable.

List visible acquired marks (brands, tattoos, scars, etc.) and location
space

Pedigree registry and registration number
space

Microchip number and location
space

Passport ID number space

Unique equine life number space

Or other unique identifier space

In the case of an EID completed by the previous owner, name of previous owner:
space

b) Picture identification

Attach 1 or more pages containing colour pictures of the animal showing the details contained in each of the views of the silhouettes below. The pictures must be clear and large enough to see the detail required. If applicable, take close ups of any visible acquired marks such as tattoos and attach. Owners ensure that the written description and pictures agree.

Silhouette

For information on how to complete the silhouette, refer to section 3.

5 silhouettes. Description follows.
Description for Silhouette:

5 silhouettes showing us: the right side view of a horse, the left side view of a horse, the face, the front view of the forelegs and the rear view of the hind legs.

Alternatives to written and picture identification

The following are alternative means of providing written and/or visual identification information. Note that the primary location of the animal and the primary use of the animal as indicated in Part 1a) is also required information.

Part 2: Medical history

I, space(name of owner) of space (space) space- space (state your full contact address: street number or post office box number/city/province or state/postal code or zip code, phone number) am the ownerFootnote 2 of the animal identified on this document and have had uninterrupted possession, care or control of this animal from space (indicate start date) to space (indicate end date).

  1. Have any drugs or vaccines been administered to or consumed by the animal during the last 180 days?

    Circle Yes or No

    If yes, write the name the drug(s) or vaccine(s), Drug Identification Number (DIN) or an equivalent, if indicated on the label, last date of use, withdrawal period(s)Footnote 3, route of administration and for drugs, the amount used (dose) per treatment if the label does not indicate a dose or if drug is used at a dosage different than the label indicates.

    space
    space

  2. Has the animal identified on this document shown signs of any illness or deviation from normal behaviour or appearance during the last 180 days?

    Are there any physical, chemical hazards or other additional items to which the animal may have been exposed that could impact food safety that should be declared such as broken needles?

    Circle Yes or No

    If yes, provide details/descriptions.

    space
    space

  3. Has the animal identified on this document been treated with a substance listed under the table named substances not permitted for use in food producing equine found in section 6?

    Circle Yes or No

Part 3: Declarations

Owner declaration

As the owner of the animal identified on this document, I hereby certify that the information stated in this EID is accurate and complete.

I understand that at least 180 continuous days of documented history covering the time period before slaughter is required by the Safe Food for Canadians Regulations (SFCR) for an equine presented for processing in an establishment that is identified in the licence for the activities with inspection services provided by the Canadian Food Inspection Agency. As such, I have the option of attaching to this document, completed Equine Information Document(s) (EID(s)) from previous owner(s) in order to cover the required 180 continuous days of documented history.

space
(Signature of owner or the entrusted person)

space/space/space
(Date DD/MM/YY)

and clearly include the contact information of the entrusted person (that is, at least, name, title (for example: trainer), address and phone number)
space
space
(space) space- space

Transient agent declaration(s)

A transient agent is a person who maintains responsibility for the care of equine from the time of purchase for slaughter until their arrival at a meat processing establishment identified in a licence in Canada.

A transient agent declaration is applicable for an animal destined for slaughter shortly (the time needed to assemble, schedule, and move to slaughter) and may not be used in lieu of an ownership declaration. In the case of more than 1 transient agent caring for the animal(s) at different times, the transient agent declaration may be repeated on the EID as many times as necessary to cover the time period prior to slaughter.

Name of agent space

Phone number (space) space- space

Address space

The animal identified on this document has been under my care and control from space(date) to space(date).

During this time period:

  1. has this animal shown signs of any illness or deviation from normal behaviour or appearance?

    Yes or No

    If yes, provide details:

    space
    space

  2. have any drugs or vaccines been administered to or consumed by the animal?

    Yes or No

    If yes, provide details:

    Any drugs or vaccines administered to or consumed by the animal
    Drug or vaccine Drug Identification Number (DIN) or an equivalent Last date of use Withdrawal period Amount used (dose) per treatment Route of administration

Signature of agent space

3. Equine written description terms

The EID requires an accurate standardized written description and visual identification that may include a completed equine outline instead of picture identification. The following terms must be used to complete the written description portion of the EID. In addition to brands or tattoos that the horse may bear, look for and identify unique distinguishing marks such as scars. Descriptive nomenclature for colouring and markings of equine as well as instructions for filling out the equine silhouette have been standardized by the International Equestrian Federation and have been adapted for use.

Height

The height of a horse is normally recorded in "hands", measured at the top of the withers.
"1 hand" equals 4 inches.

Colour

Appaloosa:
body colour is grey, covered with a mosaic of black or brown spots

Bay:
bay varies considerably in shade from dull red approaching brown, to a yellowish colour approaching chestnut, but it can be distinguished from the chestnut by the fact that the bay has a black mane and tail and almost invariably has black on the limbs and tips of the ears

Bay-brown:
the predominant colour is brown, with muzzle bay, black limbs, mane and tail

Black:
black pigment is general throughout the coat, limbs, mane and tail, with no pattern factor present other than white markings

Brown:
there is a mixture of black and brown pigment in the coat, with black limbs, mane and tail

Chestnut:
a chestnut may be any shade of red with no black points like the bay. Think of the different colours of a penny from brand new to very old and tarnished; chestnuts can come in all these colours

Also chestnuts may be described as follows if applicable:

Cream:
the body coat is of a cream colour, with nonpigmented skin. The iris is deficient in pigment and is often devoid of it, giving the eye a pinkish or bluish appearance

Dun:
the body coat is cream colour with black mane and tail

Grey:
the body coat is a varying mosaic of black and white hair, with black skin. With advancing age, the coat grows lighter in colour. The flea-bitten grey may contain 3 colours or the 2 basic colours and should be so described. A pure white is exceptional

Palomino:
the body coat is a newly-minted gold coin colour (lighter or darker shades are permissible) with a white mane and tail

Piebald:
the body coat consists of large irregular patches of black and white. The line of demarcation between the 2 colours is generally well defined

Roan:
mixture of white hairs with 1 or 2 other hair colours in the coat. May be described as red roan (white and chestnut hair), blue roan (white and black hair) as applicable

Skewbald:
the body consists of large irregular patches of white and of any definite colour except black. The line of demarcation between the colours is generally well-defined

Strawberry:
the coat is chestnut with a mixture of white hairs

Unique coat marking additional identifying terms

Black marks or dark marks:
small areas of black or dark hairs occur together with the basic (usually lighter coloured) body colour hairs

Flecked:
small collections of white hairs occur distributed irregularly in any part of the body. May be further qualified as lightly flecked or heavily flecked depending on the amount of white hair

Grey-ticked:
white hairs are sparsely distributed through the coat or any specified part of the body

Leopard:
the term leopard may be added when the horse has many more or less circular collections of hairs differing from the general body colour

List:
a dorsal band of black hair which extends from the withers backwards to the base of the tail

Patch:
this term should be used to describe any larger well-defined irregular area (not covered by previous definitions) of hairs differing from the general body colour. The colour, shape, position and extent shall be described

Spots:
small, more or less circular, collections of hairs differing from the general body colour occur, distributed in various parts of the body. The position and colour of the spots must be stated

Withers stripe:
zebra band across the withers

Zebra marks:
dark or black striping on the limbs, neck or quarters. The affected part of the animal must be stated

White marks

The characteristics of all white marks must be described.

A white mark can be regular or irregular. It can be mixed with the hair of the coat, completely or in part, or at the edge. It can be bordered, a band of black skin shows under the white hair at the edge of the mark (the area appears bluish).

Head

The description should begin at the forehead, followed by the nasal bone, the muzzle, lips and chin.

Blaze:
a white marking covering almost the whole of the forehead between the eyes and extending beyond the width of the nasal bones and usually to the muzzle. Any variations in direction, termination and any markings on the white shall be stated

Flesh mark:
lack of pigmentation. A flesh mark is described as such and not as a white mark. Black spots within the flesh mark are to be indicated. All lip markings, whether flesh marks or white marks, shall be accurately described

Snip:
an isolated white marking, independent of those already named, and situated between or in the region of the nostrils. Its size, position and intensity shall be specified. When a snip is connected with a stripe it shall be recorded as such, for example star, stripe connected snip

Star:
any white mark on the forehead. Size, shape, intensity, position and coloured markings (if any) on the white to be specified. Should the markings in the region of the center of the forehead consist of a few white hairs only, it shall be so described and not referred to as a star

Stripe:
the narrow white marking down the face not wider than the flat anterior surface of the nasal bones. In many cases, the star and stripe are continuous and should be described as star and stripe connected. When the stripe is separate and distinct from the star it shall be described as interrupted stripe. When no star is present the point of origin of the stripe shall be indicated. The termination of the stripe and any variation in breadth, direction and any markings on the white shall be so stated, for example broad stripe, narrow stripe, inclined to left, etc. Any markings in the white area shall be stated

White face:
when the white covers the forehead and front of the face, extending laterally towards the mouth. The extension may be unilateral or bilateral, in which case it shall be described accordingly

White muzzle:
when the white embraces both lips and extends to the region of the nostrils

Limbs

All white markings on the limbs must be accurately defined and the upper limit precisely stated with reference to points of the anatomy, for example white to mid-pastern, white to upper third of cannon. The use of such terms as "sock" or "stocking" are not acceptable. The exact location must be specified, examples are listed below:

The presence of coloured spots in white marks shall be recorded. Black spots in a white coronet are referred to as Ermine marks.

Hoofs:
any variation in the hoof pigment shall be noted

Whorls – Cowlicks

Whorls or cowlicks are changes in the hair pattern, and may take various forms simple, tufted, feathered or sinuous. Their position must be clearly specified with an "x" at their location on the horse.

Illustrations of white markings

Equine face markings

Equine face markings. Description follows.
Description of the illustration of the Equine face markings:

8 pictures showing equine face marking: star, snip, stripe, star stripe, white face, interrupted stripe, blaze, star strip snip.

Equine legs markings

Equine legs markings. Description follows.
Description of the illustration of the equine legs markings:

5 pictures showing equine legs marking: coronet, half pastern, pastern, mid cannon, white to knee.

The silhouette

As described in section 2, a silhouette properly filled may be used in lieu of picture identification.

4. Examination/assessment of the EID

Information documents (individual EID/lot EID) represent the means of information transfer required under the SFCR, from the equine owner to the operator of the establishment that is identified in the licence for the activities and the CFIA.

Equine owner responsibilities

The equine owner is responsible for EID and must ensure that:

Operator responsibilities

EIDs provide the operator with the necessary level of confidence that identified potential biological, chemical and physical hazards associated with live equine animals have been recorded, and to the extent possible, prevented or controlled at the farm level and during transportation. The operator must notify the CFIA immediately in the event of any discrepancy(s).

Missing or incomplete EIDs

Operators may choose 1 of the following 3 options, after notifying the CFIA, for equine that arrive at their establishment for slaughter without the appropriate or fully completed information document:

The CFIA's role

The CFIA's assessment of the EIDs reviewed by the operator allows CFIA staff to judge whether or not if the operator is implementing all necessary corrective actions and preventive measures when evaluating incoming animal information in accordance with the SFCR.

4.1 Verification of the equine slaughter operator's control over the validity of EIDs

Industry verification

Operators of equine slaughter facilities utilize transient agents (buyers) to obtain the vast majority of equine for slaughter. The transient agents (buyers) obtain equines at public auction and from private sale. Transient agents (buyers) and livestock auction market personnel are key players in the creation and transfer of EIDs. It is imperative that the information provided by equine owners and captured in the owner signed EID provides an accurate medical history and identification of the animal. To ensure an accurate EID is provided to the operator, operators must ensure equine owners and transient agents follow procedures outlined in this document, the operator's PCP.

To evaluate the operator's control over the validity of the information provided through EIDs, the CFIA will conduct verifications of the EIDs creation, update, record-keeping and transfer process. The CFIA verification evaluations apply to owners, buyers, records and equine under the care/control of equine buyers or private owners at assembly points and premises; at public auction; and at private sale premises, via an agreement having been previously signed by the operator with the various stakeholders. The CFIA has created specific tasks to guide and track CFIA verifications.

Reporting industry deficiencies and follow-up

Deficiencies found during the CFIA verification activities listed above may indicate a lack of effective operator control over the validity of EIDs. As such, the verifying CFIA inspector must contact the veterinarian with supervisory authority at the implicated operator(s) facility and provide the details of deficient findings. The veterinarian with supervisory authority or designate, provides the details of the finding to the plant operator. The operator must take appropriate compliance action related to implicated animals, or product if necessary, as well as implement/enhance their ante-mortem preventive control program and procedures as required to enhance/assure the validity of EID information. The CFIA will conduct a verification of the operators control procedures and corrective actions related to the validity of EIDs using the appropriate task.

Residue finding follow-up procedures related to EID validity

Chemical residue results that indicate residues detected in equine meat products must be investigated by the operator to determine if the implicated previously accepted EID contains declarations that may not be valid. The corresponding EID must be located by the operator. If discrepancy exists between declared drug usage and residues detected, the operator must effect corrective actions to ensure the validity of EIDs they accept is strengthened. The CFIA will conduct a verification of the operators control procedures and corrective actions related to the validity of EIDs accepted by the operator.

Measures to strengthen the EID traceability system for equine imported into Canada from the United States

A certificate, namely the Equine Certification Document (ECD), will be required for equine exported to Canada for slaughter or feeding purposes from the United States. The US accredited veterinarian will review the EID representing each equine to be exported to Canada for slaughter or feeding at the time of export certification. The ECD must be generated and signed by a veterinarian accredited within the United States Department of Agriculture (USDA) to perform equine export certification duties. The ECD must accompany export documentation to the slaughter establishment for slaughter horse importations or to the feedlot for feeder horse importations.

The Equine Certification Document must state:

I space have verified that all equine included on the Export Health Certificate number: space, are accompanied with an Equine Information Document (EID) properly completed and signed by the owner.

Number of EIDs that accompany the Health Certificate: space

space
Signature of accredited veterinarian

space
Date

Business contact information of the accredited veterinarian including business name, address and phone number.
space
space

It is strongly recommended that the US accredited veterinarian utilize the statement above on their veterinary company letterhead which provides their company name, address and phone number to generate the Equine Certification Document (ECD).

5. Equine Lot Program

An owner of a group(s)/lot(s) of equine animals intended as food animals may be eligible to present the animals to slaughter via a collective lot declaration.

In order to avoid confusion with any other method of identification, the method of identifying the Equine Lot Program must be unique to each lot owner and for each lot (for example: owner's ID and lot ID »» XYZ 2021-1). This method must be submitted to the operator for examination and approval and presented to the veterinarian with supervisory authority for assessment of program compliance (which includes the SFCR's requirements) prior to use. Failing to do so will lead to rejection of the lot at the time of slaughter.

There are a number of advantages to the lot program:

Standards for establishing a group (lot) of equine intended for slaughter

Equine Lot Program elements

The prospective lot owner will submit written details of the proposed method of lot identification they wish to use to ensure uniqueness, traceability and compliance to the SFCR. The method must receive approval from the operator and meet CFIA requirements prior to use.

6. List of veterinary drugs not permitted for use in equine slaughtered for food with Canadian brand name examples (March 10, 2010)

Non permitted drug name Examples of brand or common names Species indicated on the label
5-Nitroimidazoles including dimetridazole, metronidazole, and ronidazole

Banned by regulations Table Note 4 for sale in food producing animals in Canada.

Not approved for veterinary use in Canada.

N/A
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin

Carbadox not currently marketed in Canada (stop sale order in effect)

Olaquindox not approved for veterinary use in Canada
N/A
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin There are no antimicrobials approved for use as growth promotants for equine in Canada. Equine animals treated with antibiotics for growth promotion reasons are not eligible for slaughter in Canada. Several antimicrobials (for example, bacitracin, bambermycin, chlortetracycline, lincomycin, procaine penicillin, tylosin, virginiamycin etc.) have label claims for growth promotion/feed efficiency in other food producing animals (for example, cattle, swine, poultry).
Aristolochia species and preparations thereof Not approved for veterinary use in Canada. N/A
Arsanilic acid
  • 3-Nitro-20
Chicken, turkey and swine
Arsanilic acid
  • Histostat 50
Turkey
Arsanilic acid
  • Pro-Gen 20%
  • Pro-Gen 100%
Chicken and turkey
Beta-agonists used for growth promotion purposes, including clenbuterol and ractopamine Clenbuterol
Banned by regulations Table Note 4 for sale in food producing animals in Canada.
N/A
Beta-agonists used for growth promotion purposes, including clenbuterol and ractopamine

Ractopamine

  • Optaflexx 100 Premix

Zilpaterol hydrochloride

  • Zilmax Medicated Premix
Cattle
Beta-agonists used for growth promotion purposes, including clenbuterol and ractopamine
  • Paylean 20
Swine
Beta-agonists used for growth promotion purposes, including clenbuterol and ractopamine
  • Ventipulmin Solution
  • Ventipulmin Syrup
Horses not intended for food
Boldenone
  • Equipoise Injectable
  • Equipoise
Horses not intended for food
Chloramphenicol

Banned by regulations Table Note 4 for sale in food producing animals in Canada.

  • Chlor-500
  • Chlor-1000
  • Chloramphenicol 1% ointment
  • ChlorPalm 250
Dog and cat
Chloroform Approved as a veterinary drug in Canada, however currently not manufactured N/A
Chlorpromazine Not approved for veterinary use in Canada. N/A
Colchicine Not approved for veterinary use in Canada. N/A
Dapsone Not approved for veterinary use in Canada. N/A
Estradiol (for estradiol containing implants, see steroidal hormones below)
  • Estradiol Cypionate in oil
Horses not intended for food, cattle, dog and cat
Estradiol (for estradiol containing implants, see steroidal hormones below)
  • Estrus
Cattle
Estradiol (for estradiol containing implants, see steroidal hormones below)
  • Uni-Bol
Horses not intended for food
Methandriol Not approved for veterinary use in Canada. N/A
Nitrofurans including furaltadone, furazolidone, nitrofurantoin, nitrofurazone

Banned by regulations Table Note 4 for sale in food producing animals in Canada.

Furazolidone not approved for veterinary use in Canada.

Furox Aerosol Powder, Topazone Aerosol Powder, Furall registered for veterinary use in the USA.

Furaltadone not approved for veterinary use in Canada

N/A
Nitrofurans including furaltadone, furazolidone, nitrofurantoin, nitrofurazone
  • Nitro Ointment
  • Nitrofur Solution
Horses not intended for food
Nitrofurans including furaltadone, furazolidone, nitrofurantoin, nitrofurazone

Nitrofurantoin

  • Equifur
Horses not intended for food, dog and cat
Nitrofurans including furaltadone, furazolidone, nitrofurantoin, nitrofurazone

Nitrofurazone

  • Niderm Ointment
Horses not intended for food
Nitrofurans including furaltadone, furazolidone, nitrofurantoin, nitrofurazone
  • Nitrofurazone Ointment
General use
Nitrofurans including furaltadone, furazolidone, nitrofurantoin, nitrofurazone
  • Pinkaway Powder
Dog and cat
Phenylbutazone
  • Butazone 400
  • Butazone 1000
  • Butazone Concentrate
  • Butequine
  • Buzone Concentrate
  • Phenylbutazone
  • Phenylbutazone Injection(inj.)
  • Phenylbutazone Powder
  • Phenylbutazone Tablets
  • Phenylbutazone Tabs
Note: all of the products listed carry an indication for use in equine (but not equine intended to be slaughtered for food)
Resorcylic acid lactones including zeranol

Zeranol

  • Ralgro

Beef

Note that this product carries only a cattle indication

Stanozolol No active products for veterinary use in Canada. N/A
Steroidal hormonal implants used for growth promotion purposes Equine animals treated with steroid containing hormone implants used to promote growth are not eligible for slaughter in Canada. Note that these products carry only a cattle indication. Hormonal implants containing estradiol or melengestrol acetate singly, or the combinations of estradiol and progesterone; estradiol and testosterone; estradiol and trenbolone acetate etc. sold under different brand names for use in cattle.
Stilbenes, stilbene derivatives, and their salts and esters including diethylstilbestrol

Banned by regulations Table Note 4 for sale in food producing animals in Canada.

Diethylstilbestrol

  • Stilbestrol
  • Stilbestrol Tablets
Dog and cat
Testosterone
  • Testosterone Propionate Injection (Dominion)
  • Uni-Test (Uni–Vet)
Horses not intended for food
Thyrostats, antithyroid agents administered under any circumstances for the purpose of growth promotion Approved for use in humans. Use in animals would be under veterinary control, but animals treated with these substances would not be eligible for slaughter. N/A

N/A: Not applicable as these active ingredients are not approved for veterinary use in Canada.

7. List of "essential" veterinary drugs permitted in equine with a 180 day withdrawal period with Canadian brand name examples

Drug use Drug Canadian brand name examples
Analgesia
  • Buprenorphine
  • Fentanyl
  • Morphine
  • Pethidine
No known manufacture for veterinary use in Canada
Antimicrobials
  • Amikacin
Amiglyde-V
Antimicrobials
  • Azithromycin
  • Rifampicin
  • Ticarcillin
No known manufacture for veterinary use in Canada
Antiprotozoal
  • Isometamidium
No known manufacture for veterinary use in Canada
Antiprotozoal
  • Pyrimethamine
Quinnoxine-S
Sulfaquinoxaline-S
Cardiovascular
  • Digoxin
  • Procainamide
  • Propanolol
  • Quinidine sulfate and quinidine gluconate
No known manufacture for veterinary use in Canada
Convulsions
  • Phenytoin
  • Primidone
No known manufacture for veterinary use in Canada
Fungal infection
  • Griseofulvin
  • Ketoconazole
No known manufacture for veterinary use in Canada
Fungal infection
  • Miconazole
Conofite Cream 2%
Dermazole Shampoo
Surolan Drops
Fungal infection
  • Nystatin
Canaural Ear Drops
Panalog Cream
Panalog Ointment
Gastrointestinal
  • Bethanechol
  • Dioctyl Sodium Sulfosuccinate
  • Metoclopramide
  • Propantheline bromide
No known manufacture for veterinary use in Canada
Hyperlipaemia
  • Insulin
Caninsulin
Hypotension or respiratory stimulation during anaesthesia
  • Ephedrine
Antihistamine
Antihistamine Powder
Antihist Solution
Pyrahist-10
Hypotension or respiratory stimulation during anaesthesia
  • Dobutamine
  • Dopamine
  • Glycopyrrolate
  • Noradrenaline
No known manufacture for veterinary use in Canada
Inhalation anaesthetics
  • Sevoflurane
No known manufacture for veterinary use in Canada
Local anaesthetics
  • Bupivacaine
  • Oxybuprocaine
  • Prilocaine
No known manufacture for veterinary use in Canada
Muscle relaxants and associated substances
  • Atracurium
  • Edrophonium
No known manufacture for veterinary use in Canada
Muscle relaxants and associated substances
  • Guaifenesin
No known manufacture for veterinary use in Canada for the use indicated
Ophthalmic
  • Cyclosporin A
Optimmune
Ophthalmic
  • Acyclovir
  • Dorzolamide
  • Fluoresceine
  • Hydroxypropyl methylcellulose
  • Idoxuridine
  • Ketorolac
  • Latanoprost
  • Ofloxacin
  • Phenylephrine
  • Rose Bengal
  • Timolol maleate
  • Tropicamide
No known manufacture for veterinary use in Canada
Respiratory
  • Ambroxol
  • Ipratropium bromide
  • Oxymetazoline
No known manufacture for veterinary use in Canada
Rhabdomyolysis
  • Dantrolene sodium
No known manufacture for veterinary use in Canada
Sedation and premedication (and antagonism)
  • Acepromazine
Ace
Acevet 10 Tablets
Acevet 25 Tablets
Acevet Injection
Atravet 10 mg Injectable
Atravet Soluble Granules
Sedation and premedication (and antagonism)
  • Atipamezole
Antisedan
Sedation and premedication (and antagonism)
  • Diazepam
  • Midazolam
  • Naloxone
No known manufacture for veterinary use in Canada
Sedation and premedication (and antagonism)
  • Propofol
PropoFlo
Rapinovet
Sedation and premedication (and antagonism)
  • Sarmazenil
  • Tiletamine
  • Zolazepam
No known manufacture for veterinary use in Canada
Miscellaneous
  • Chondroitin Sulfate
Chotin
Miscellaneous
  • Barium sulphate
  • Domperidone
  • Hydroxyethyl starch
  • Imipramine
  • Iohexol
  • Iopamidol
  • Thyrotropin releasing hormone
No known manufacture for veterinary use in Canada

8. List of veterinary drugs safe for use in equine intended for food production for which withdrawal periods have been determined with Canadian brand name examples

Health Canada recommends the following provisional withdrawal periods (WP) for veterinary drugs in equine intended for food production. The following table will be updated periodically with the inclusion of new drugs or revised withdrawal periods, when additional information (for example, new data from the drug sponsor) becomes available. When the label recommended WPs are not specific to equine, Health Canada recommends using the provisional WPs listed in the following table.

Antimicrobials
Drug Approved Canadian products Route WP
Amikacin
  • Amiglyde-V (Wyeth)
Intrauterine 6 months
Benzathine penicillin
(in combination with procaine penicillin)
  • Benzapro Liquid (Medprodex)
  • Duplocillin LA (Intervet)
  • Longisil (Vetoquinol)
  • Procillin LA (Bimeda-MTC)
Intramuscular (IM) 60 days
Ceftiofur
  • Excenel Sterile Powder for injection(inj.) (Pfizer)
IM 5 days
Gentamicin
  • Gentocin (Intervet)
Intrauterine 45 days
Neomycin

Neomycin (± astringents ± electrolytes ± anticholinergic):

  • Biosol Liquid (Pfizer)
  • NeoMed 325 (Bio Agri Mix)
  • Neomix Soluble powder (Pfizer)
  • Neomycin 325 (Vetoquinol)
  • Scour Solution CO-OP (IPCO)
  • Scour Solution (Vetoquinol)
Oral 30 days
Neomycin and sulphonamide combinations

Neomycin and sulfonamides (± astringents ± electrolytes ± anticholinergic):

  • Calf Scour Bolus (PVL)
  • Neorease (Bimeda-MTC)
  • NeoSulfalyte Bolus (Pfizer)
  • Scour-Plug (Can-Vet)
  • Scour Treat (Citadel)
  • Super Scour Calf Bolus (Dominion)
Oral 30 days
Procaine penicillin
  • Co-op Penicillin G procaine Inj (IPCO)
  • Depocillin (Intervet)
  • Hi-Pencin 300 (Remedy Animal Health/Equivet)
  • Pen Aqueous (Wyeth)
  • Pen G inj. (Citadel)
  • Penicillin G procaine (Vetoquinol)
  • Penicillin G procaine (Novopharm)
  • Penmed (Medprodex)
  • Penpro (Vetoquinol)
  • Pen Vet 300 (Alfasan/Rafter 8)
  • Procaine Penicillin G (Dominion)
  • Procillin (Bimeda-MTC)
IM 28 days
Potentiated sulfonamides

Sulfonamide-trimethoprim (Oral):

  • Uniprim Oral Powder (Macleod)
  • Uniprim Oral Granules (Macleod)
Oral 7 days
Potentiated sulfonamides

Sulfonamidetrimethoprim (Injectable):

  • Tribrissen 48% (Intervet/Schering)
Intravenous (IV), IM 12 days
Sulfonamides Table Note 5

Sulfonamides (± astringents ± electrolytes ± anticholinergic):

  • Sodium Sulfamethazine Liq 25% (Citadel)
  • Sulfa 25% Solution (Bimeda-MTC)
  • Sulfamethazine Bolus 15 g (Dominion)
  • Sulfamethazine Bolus 15 g (PVL)
  • Triple Sulfa Bolus (PVL)
  • Triple Sulfa Bolus (Dominion)
Oral 12 days
Tetracycline
  • Tetra 4000 (Jaapharm)

Orale
Intrauterine

O: 5 days
IU:18 days

Tetracycline
  • Tetrabol (Vetoquinol)
Intrauterine 18 days
Parasiticides
Drug Approved Canadian products Route WP
Fenbendazole
  • Panacur granules 22.2% (Intervet)
  • Panacur paste 10% (Intervet)
  • Panacur suspension 10% (Intervet)
  • Safe-Guard paste 10% (Intervet)
  • Safe-Guard suspension 10% (Intervet)
Oral 13 days
Ivermectin
  • Bimectin oral paste (Bimeda-MTC)
  • Equell oral paste (Vibrac/ Pfizer)
  • Eqvalan liquid (Merial)
  • Eqvalan paste (Merial)
  • Panomec oral paste (Merial)
  • Zimecterin paste (Merial)
Oral 28 days
Ivermectin and praziquantel
  • Equimax Oral Paste (Vibrac/ Bimeda-MTC/ Pfizer/ Vetoquinol)
  • Eqvalan Gold paste (Merial)
Oral 28 days
Moxidectin Quest Gel (Wyeth) Oral 36 days
Moxidectin and praziquantel Quest Plus Gel (Wyeth) Oral 36 days
Piperazine

Powder/pellet formulations:

  • Alfalfa Pellet Horse Wormer 50% (Farnam)
  • Co-op Wormer 52% (IPCO)
  • Piperazine 52 (Vetoquinol)
  • Piperazine 100 oral powder (Medprodex)
  • Piperazine Dihydrochloride 53% (Dominion)
  • Piperazine Dihydrochloride 53% (PVL)
  • Wonder Wormer for Horses 100% (Farnam)

Liquid formulations:

  • Piperazine 34 (Vetoquinol)
  • Piperazine 34 liq (PVL)
  • Super Pipzine 34% (Dominion)
Oral 21 days
Pyrantel
  • Exodus paste 23.6 g (Bimeda-MTC)
  • Exodus paste 47.2 g (Bimeda-MTC)
  • Strongid P (Pfizer)
  • Strongid T (Pfizer)
Oral 7 days
Tranquilizers/Sedatives/Anaesthetics
Drug Approved Canadian products Route WP
Acepromazine

Oral formulations:

  • Ace Powder (Jaapharm)
  • Atravet Soluble Granules (Wyeth)
Oral 6 months
Acepromazine

Injectable formulations:

  • Acepro-25 (Bimeda-MTC)
  • Acepromazine Inj (Univet)
  • Acevet (Vetoquinol)
  • Atravet Inj (Wyeth)
IM, IV 6 months
Butorphanol Torbugesic (Wyeth) IV 7 days
Detomidine Dormosedan (Orion/Pfizer) IM, IV 7 days
Lidocaine Lidocaine Neat (Wyeth)
Lurocaine (Vetoquinol)
Subcutaneous (SC), IM 7 days
Lidocaine and epinephrine
  • Lido-2 (Rafter 8; lidocaine HCl - 20 mg/mL, epinephrine HCl - 0.01 mg/mL)
  • Lidocaine 2% Sterile inj. (Vetoquinol, Lidocaine HCl - 20 mg/mL, epinephrine 0.01 mg/mL)
  • Lidocaine HCl 2% (Wyeth; lidocaine HCl 20 mg/mL, epinephrine HCl - 0.01 mg/mL)
  • Lidocaine HCl 2% with Epinephrine 1:100,000 (Dominion)
  • Lidocaine HCl 2% with Epinephrine (Bimeda-MTC)
  • Lidocaine HCl 2% with Epinephrine 1:100,000 (P.V.L)
SC, IM 7 days
Romifidine Sedivet (Boehringer) IV 14 days
Thiopental Thiotal 1 G (Vetoquinol)
Thiotal 5 G (Vetoquinol)
IV 7 days
Xylazine
  • Anased Inj 100 mg/mL (Vet-A-Mix)
  • NvAnased inj.100 mg/mL (Novopharm)
  • Rompun inj.100 mg/mL (Bayer)
  • Xylamax inj.100 (Bimeda-MTC)
IM, IV 35 days
Glucocorticoids
Drug Approved Canadian products Route WP
Dexamethasone
  • Dexacort 5 (Rafter 8)
  • Dexamethasone 2 (Vetoquinol)
  • Dexamethasone 5 (Vetoquinol)
  • Dexamethasone 21-phosphate inj. (Dominion)
  • Dexamethasone inj. 2 mg/mL (Dominion)
  • Dexamethasone inj. 2 mg/mL (P.V.L)
  • Dexamethasone pwr (Dominion)
  • Dexamethasone powder (Vetoquinol)
  • Dexone (Jaapharm)
  • Rafter Dex (Alfasan/Rafter 8)
  • UniDex (Univet)
Oral, IV, IM 21 days
Dexamethasone and trichlormethiazide Naquasone (Schering) IM 21 days
Prednisolone
  • Depo-Medrol (Pfizer)
  • Depo-Medrol sterile aqueous suspension (Pfizer)
  • Methylprednisolone acetate (PVL)
  • Prednisolone inj. (Vetoquinol)
  • Prednisolone Acetate inj. (Dominion)
  • Prednisolone Acetate sus (PVL)
  • Prednisolone Sod Succinate (Univet)
  • Solu-Delta-Cortef (Pfizer)
  • Solu-Delta-Cortef sterile solution (Pfizer)
  • Uni-Med (Univet)
  • Uni Pred 50 (Univet)
  • Vetacortyl (Vetoquinol)
IM, IV, Intra-articular 28 days
Nonsteroidal antiinflammatory
Drug Approved Canadian products Route WP
Flunixin
  • Banamine solution (Schering)
  • Cronyxin Inj (Cross Vetpharm/Bioniche)
  • Flunazine (Bimeda-MTC)
  • Flunixin Injection (Norbrook/Wyeth)
  • Influx-50 (Vetoquinol)
  • Suppressor (Norbrook/Kane)
IM, IV

IV:10 days

IM: 30 days

Ketoprofen Anafen inj.100 mg/mL (Merial) IM, IV 7 days
Vedaprofen Quadrisol 100 (Intervet) Oral 21 days
Vedaprofen Quadrisol 50 Inj (Intervet) IV 21 days
Steroids
Drug Approved Canadian products Route WP
Altrenogest Regu-mate solution 0.22% (Intervet) Oral 42 days
Progesterone Table Note 6 Progesterone 5% (Vetoquinol) IM 14 days
Miscellaneous
Drug Approved Canadian products Route WP
Furosemide Furosemide inj. (Sandoz)
Salix inj. (Intervet)
IM, IV 7 days
Omeprazole Gastrogard (Merial) Oral 3 days
Sodium iodide
  • Sodide (Rafter 8)
  • Sodium Iodide (Bimeda-MTC)
  • Sodium Iodide 20% inj. (Univet)
  • Sodium Iodide inj. 20% (Dominion)
  • Sodium Iodide inj. 20% (PVL)
IV 0 days
Trichlormethiazide and dexamethasone Naquasone (Schering) IM 21 days
Date modified: